Report

TABLE OF CONTENTS
1 INTRODUCTION 75
1.1 OBJECTIVES OF THE STUDY 75
1.2 MARKET DEFINITION 75
1.3 OVERVIEW OF THE EUROPE COMPRESSION GARMENTS AND STOCKINGS MARKET 75
1.4 CURRENCY AND PRICING 77
1.5 LIMITATIONS 77
1.6 MARKETS COVERED 77
2 MARKET SEGMENTATION 81
2.1 MARKETS COVERED 81
2.2 GEOGRAPHICAL SCOPE 82
2.3 YEARS CONSIDERED FOR THE STUDY 83
2.4 DBMR TRIPOD DATA VALIDATION MODEL 84
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 87
2.6 MULTIVARIATE MODELLING 88
2.7 PRODUCT TYPE LIFELINE CURVE 89
2.8 MARKET END USER COVERAGE GRID 90
2.9 DBMR MARKET POSITION GRID 91
2.10 VENDOR SHARE ANALYSIS 92
2.11 SECONDARY SOURCES 93
2.12 ASSUMPTIONS 93
3 EXECUTIVE SUMMARY 94
4 PREMIUM INSIGHTS 99
4.1 IMPORT EXPORT SCENARIO 100
4.2 PATENT ANALYSIS - 101
4.2.1 PATENT QUALITY AND STRENGTH 101
4.2.2 PATENT FAMILIES 101
4.2.3 LICENSING AND COLLABORATIONS 102
4.2.4 COMPETITIVE LANDSCAPE 103
4.2.5 IP STRATEGY AND MANAGEMENT 104
4.3 VENDOR SELECTION CRITERIA 105
4.3.1 QUALITY AND CONSISTENCY OF SUPPLY 105
4.3.2 RELIABILITY AND TIMELINESS 106
4.3.3 COST COMPETITIVENESS 106
4.3.4 TECHNICAL CAPABILITY AND INNOVATION 106
4.3.5 REGULATORY COMPLIANCE AND SUSTAINABILITY 106
4.3.6 FINANCIAL STABILITY 106
4.3.7 CUSTOMER SERVICE AND SUPPORT 106
4.4 BRAND OUTLOOK 107
4.5 COMPETITIVE BENCHMARKING ACROSS COMPRESSION LEVEL, FABRIC TYPE, AND DISTRIBUTION CHANNEL 108
4.5.1 COMPRESSION LEVEL BENCHMARKING 108
4.5.2 FABRIC TYPE BENCHMARKING 108
4.5.3 DISTRIBUTION CHANNEL BENCHMARKING 109
4.5.4 COMPETITIVE INSIGHTS 109
4.6 CONSUMER BUYING BEHAVIOUR 110
4.6.1 PROBLEM RECOGNITION AND AWARENESS 110
4.6.2 INFORMATION SEARCH 110
4.6.3 EVALUATION OF ALTERNATIVES 110
4.6.4 PURCHASE DECISION 110
4.6.5 POST-PURCHASE BEHAVIOUR 110
4.6.6 DEMOGRAPHIC INSIGHTS 111
4.6.7 CONCLUSION 111
4.7 COST ANALYSIS BREAKDOWN 112
4.7.1 RAW MATERIAL COST DYNAMICS 112
4.7.2 MANUFACTURING AND PROCESSING COSTS 112
4.7.3 REGULATORY COMPLIANCE AND CERTIFICATION COSTS 112
4.7.4 PACKAGING AND DISTRIBUTION EXPENSES 113
4.7.5 R&D AND TECHNOLOGICAL INNOVATION COSTS 113
4.7.6 MARKET-BASED PRICE BENCHMARKS 113
4.7.7 GEOGRAPHICAL VARIATIONS IN COST STRUCTURES 113
4.7.8 IMPACT ON PROFITABILITY AND STRATEGIC IMPLICATIONS 114
4.7.9 CONCLUSION 114
4.8 PROFIT MARGIN SCENARIO 115
4.8.1 INTRODUCTION TO PROFIT MARGINS IN MEDICAL TEXTILES 115
4.8.2 COST STRUCTURES AND MARGIN INFLUENCERS 115
4.8.3 PROFITABILITY BY PRODUCT TYPE 115
4.8.4 GEOGRAPHICAL MARGIN COMPARISON 115
4.8.5 PRIVATE LABELS VS. BRANDED PRODUCTS 116
4.8.6 IMPACT OF REGULATIONS ON PROFIT MARGINS 116
4.8.7 DIGITAL DISTRIBUTION AND DIRECT-TO-CONSUMER (D2C) PROFITABILITY 116
4.8.8 CONCLUSION 116
4.9 END USER EVOLUTION ANALYSIS - EUROPE COMPRESSION GARMENTS AND STOCKINGS MARKET 117
4.9.1 CONCLUSION 120
4.10 IMPACT OF SUSTAINABILITY AND CIRCULAR FASHION INITIATIVES ON PRODUCT DEVELOPMENT 121
4.10.1 RECYCLABLE FIBERS AND ECO-FRIENDLY MATERIALS 121
4.10.2 CIRCULAR DESIGN AND EXTENDED PRODUCT LIFE 121
4.10.3 ECO-COMPLIANT INNOVATIONS IN COMPRESSION TECHNOLOGY 121
4.10.4 MARKET DRIVERS FOR SUSTAINABILITY IN COMPRESSION WEAR 122
4.10.5 CHALLENGES IN SUSTAINABLE PRODUCT DEVELOPMENT 122
4.10.6 CONCLUSION 122
4.11 INNOVATION TRACKER AND STRATEGIC ANALYSIS 123
4.11.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS 123
4.11.1.1 Joint Ventures 123
4.11.1.2 Mergers and Acquisitions 123
4.11.1.3 Licensing and Partnership 124
4.11.1.4 Technology Collaborations 124
4.11.1.5 Strategic Divestments 125
4.11.2 NUMBER OF PRODUCTS IN DEVELOPMENT 125
4.11.3 STAGE OF DEVELOPMENT 126
4.11.4 TIMELINES AND MILESTONES 126
4.11.5 INNOVATION STRATEGIES AND METHODOLOGIES 127
4.11.6 RISK ASSESSMENT AND MITIGATION 127
4.11.7 FUTURE OUTLOOK 128
4.12 RAW MATERIAL COVERAGE 129
4.12.1 INTRODUCTION 129
4.12.2 FOUNDATION OF RAW MATERIAL USE 129
4.12.3 DEPENDENCE ON SYNTHETIC FIBERS 129
4.12.4 INTEGRATION OF NATURAL FIBERS 130
4.12.5 ADOPTION OF TECHNICAL AND FUNCTIONAL TEXTILES 131
4.12.6 SUSTAINABLE MATERIAL INNOVATIONS 131
4.12.7 REGULATORY AND QUALITY COMPLIANCE 132
4.12.8 SUPPLY CHAIN CONSIDERATIONS 132
4.12.9 LIFECYCLE AND PERFORMANCE ATTRIBUTES 133
4.12.10 CONCLUSION 134
4.13 VALUE CHAIN 135
4.13.1 EUROPE COMPRESSION GARMENTS AND STOCKINGS MARKET VALUE CHAIN 135
4.13.2 RAW MATERIAL SOURCING & MANUFACTURING: 135
4.13.3 PRODUCT DESIGN & COMPONENT MANUFACTURING - 136
4.13.4 ASSEMBLY, BRANDING & PACKAGING 137
4.13.5 DISTRIBUTION & END-USE 138
4.14 SUPPLY CHAIN ANALYSIS 139
4.14.1 RAW MATERIAL SUPPLIERS 140
4.14.2 TEXTILE MANUFACTURERS 140
4.14.3 GARMENT & COMPONENT MANUFACTURERS 140
4.14.4 DESIGN, TESTING & ASSEMBLY UNITS 141
4.14.5 DISTRIBUTORS & RETAIL CHANNELS 141
4.14.6 MEDICAL PROFESSIONALS / PRESCRIBERS 142
4.14.7 END USERS 142
4.15 PORTER'S FIVE FORCES 143
4.15.1 INTENSITY OF COMPETITIVE RIVALRY - MODERATE TO HIGH 143
4.15.2 BARGAINING POWER OF BUYERS/CONSUMERS (MODERATE TO HIGH) 144
4.15.3 THREAT OF NEW ENTRANTS (LOW TO MODERATE) 144
4.15.4 THREAT OF SUBSTITUTE PRODUCTS ( LOW TO MODERATE) 145
4.15.5 BARGAINING POWER OF SUPPLIERS (MODERATE) 145
4.16 CLIMATE CHANGE SCENARIO 146
4.16.1 INTRODUCTION 146
4.16.2 ENVIRONMENTAL CONCERNS 146
4.16.3 INDUSTRY RESPONSE 146
4.16.4 GOVERNMENT'S ROLE 147
4.16.5 ANALYST RECOMMENDATIONS 147
4.16.6 CONCLUSION 148
4.17 INDUSTRY ECOSYSTEM ANALYSIS 149
4.18 INTRODUCTION 149
4.18.1 PROMINENT COMPANIES 149
4.18.2 SMALL & MEDIUM SIZE COMPANIES 149
4.18.3 END USERS 149
4.18.4 CONCLUSION 150
4.19 STRATEGIC INITIATIVE ASSESSMENTS (CORPORATE WELLNESS PARTNERSHIPS, RETAIL COLLABORATIONS, OEM/ODM ARRANGEMENTS) ACROSS KEY GEOGRAPHIES 151
4.19.1 CORPORATE WELLNESS PARTNERSHIPS: INTEGRATING COMPRESSION SOLUTIONS INTO HOLISTIC HEALTH FRAMEWORKS 151
4.19.2 RETAIL COLLABORATIONS 151
4.19.3 OEM/ODM ARRANGEMENTS: COST-OPTIMIZED, CUSTOM-BUILT MANUFACTURING PARTNERSHIPS 152
4.19.4 GEOGRAPHY-SPECIFIC STRATEGIES 152
4.19.5 STRATEGIC DECISIONS CROSS-FUNCTIONAL EUROPE STRATEGY: UNIFYING PARTNERSHIPS FOR MARKET SYNERGY 153
4.19.6 CONCLUSION 153
4.20 TECHNOLOGICAL ADVANCEMENTS 154
4.20.1 TECHNOLOGICAL ADVANCEMENTS IN THE EUROPE COMPRESSION GARMENTS AND STOCKINGS MARKET 154
4.20.2 SMART COMPRESSION TEXTILES AND WEARABLE SENSORS 154
4.20.3 3D KNITTING AND SEAMLESS CONSTRUCTION TECHNOLOGIES 154
4.20.4 ADVANCED AND FUNCTIONAL MATERIALS 154
4.20.5 AI-POWERED CUSTOMIZATION AND ON-DEMAND MANUFACTURING 154
4.20.6 INTEGRATION WITH DIGITAL THERAPEUTICS AND TELEHEALTH 155
4.20.7 SUSTAINABLE AND ECO-FRIENDLY INNOVATIONS 155
4.20.8 AUTOMATION AND QUALITY CONTROL IN MANUFACTURING 155
4.20.9 CONCLUSION 155
4.21 TARIFFS & IMPACT ON THE EUROPE COMPRESSION GARMENTS AND STOCKINGS MARKET 156
4.21.1 OVERVIEW 156
4.21.2 CURRENT TARIFF RATE (S) IN TOP-5 COUNTRY MARKETS 156
4.21.3 OUTLOOK: LOCAL PRODUCTION VS. IMPORT RELIANCE 157
4.21.4 VENDOR SELECTION CRITERIA DYNAMICS 158
4.21.5 IMPACT ON SUPPLY CHAIN 159
4.21.5.1 Introduction 159
4.21.5.2 RAW MATERIAL PROCUREMENT 159
4.21.5.3 Manufacturing and Production 160
4.21.5.4 Logistics and Distribution 160
4.21.5.5 Conclusion 160
4.21.6 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 160
4.21.6.1 SUPPLY CHAIN OPTIMIZATION 160
4.21.6.2 JOINT VENTURE ESTABLISHMENTS 161
4.21.7 IMPACT ON PRICES 162
4.21.7.1 Influence of Raw Material and Textile Innovations 162
4.21.7.2 Technological Advancements and Customization 163
4.21.7.3 Regulatory Compliance and Quality Standards 163
4.21.7.4 Logistics, Distribution, and Retail Dynamics 163
4.21.7.5 Sustainability and Ethical Production 164
4.21.7.6 Economic and Europe Trade Factors 164
4.21.8 REGULATORY INCLINATION 164
4.21.8.1 Evolving Classification Standards 165
4.21.8.2 Compliance and Quality Assurance 165
4.21.8.3 Cross-Border Challenges 165
4.21.8.4 Digital Integration and Regulation 165
4.21.8.5 Geopolitical Situation 165
4.21.8.6 Trade Partnerships Between the Countries 166
4.21.8.7 Free Trade Agreements 166
4.21.8.8 Alliances Establishments 166
4.21.8.9 Conclusion 167
4.21.9 STATUS ACCREDITATION (INCLUDING MFTN) IN THE EUROPE COMPRESSION GARMENTS AND STOCKINGS MARKET 168
4.21.9.1 Medical Accreditation and Regulatory Compliance 168
4.21.9.2 Voluntary Certifications and Quality Seals 168
4.21.9.3 Role of MFTN (Medical Functional Textile Network) 168
4.21.9.4 Accreditation as a Strategic Differentiator 168
4.21.9.5 Domestic Course of Correction in the Europe Compression Garments and Stockings Market 169
4.21.9.6 Incentive Schemes to Boost Production Outputs 169
4.21.9.7 Establishment of Special Economic Zones / Industrial Parks 169
4.21.9.8 Conclusion 170
4.22 PRICING ANALYSIS 171
4.23 PRODUCTION CONSUMPTION ANALYSIS 172
4.24 COMPANY COMPARATIVE ANALYSIS AND POSITIONING MATRICES FOR LIFESTYLE VS. THERAPEUTIC BRANDS 173
4.24.1 COMPANY COMPARATIVE ANALYSIS: LIFESTYLE VS. THERAPEUTIC FOCUS 173
4.24.2 POSITIONING MATRIX INSIGHTS: 173
4.24.2.1 BAUERFEIND AG 173
4.24.2.2 3M 173
4.24.2.3 CARDINAL HEALTH 173
4.24.2.4 THUASNE 174
4.24.2.5 LOHMANN & RAUSCHER GMBH & CO. KG 174
5 REGULATION COVERAGE 175
5.1 INTRODUCTION 175
5.2 PRODUCT CODES 175
5.3 CERTIFIED STANDARDS 175
5.4 SAFETY STANDARDS 176
5.5 MATERIAL HANDLING AND STORAGE 176
5.6 TRANSPORT AND PRECAUTIONS 176
5.7 HAZARD IDENTIFICATION 176
5.8 CONCLUSION 177
6 MARKET OVERVIEW 178
6.1 DRIVERS 180
6.1.1 INCREASING OBESITY AND SEDENTARY LIFESTYLES 180
6.1.2 RISING USE OF COMPRESSION WEAR IN SPORTS RECOVERY 181
6.1.3 ADVANCEMENTS IN TEXTILE TECHNOLOGY AND MATERIALS 182
6.1.4 GROWTH OF HOME-BASED AND OUTPATIENT CARE SERVICES 183
6.2 RESTRAINTS 184
6.2.1 SHORTAGE OF TRAINED PERSONNEL FOR PROPER FITTING 184
6.2.2 LIMITED CLINICAL BACKING IN NON-THERAPEUTIC USE CASES 185
6.3 OPPORTUNITIES 186
6.3.1 DEMAND FOR SUSTAINABLE AND ECO-FRIENDLY COMPRESSION FABRICS 186
6.3.2 COLLABORATION WITH FASHION AND WELLNESS BRANDS 187
6.3.3 GROWING SALES FROM E-COMMERCE SECTOR 188
6.4 CHALLENGES 189
6.4.1 LOW AWARENESS AND DIAGNOSTIC ACCESS IN RURAL AREAS 189
6.4.2 COMPLEX REGULATORY CLASSIFICATION ACROSS MARKETS 190
7 EUROPE COMPRESSION GARMENTS AND STOCKINGS MARKET, BY PRODUCT TYPE 192
7.1 OVERVIEW 193
7.2 COMPRESSION STOCKINGS 196
7.3 COMPRESSION GARMENTS 199
8 EUROPE COMPRESSION GARMENTS AND STOCKINGS MARKET, BY COMPRESSION LEVEL 201
8.1 OVERVIEW 202
8.2 MODERATE COMPRESSION 205
8.3 MILD COMPRESSION 206
8.4 FIRM COMPRESSION 206
8.5 EXTRA-FIRM COMPRESSION 207
9 EUROPE COMPRESSION GARMENTS AND STOCKINGS MARKET, BY APPLICATION 208
9.1 OVERVIEW 209
9.2 MEDICAL USE 212
9.3 NON-MEDICAL USE 213
10 EUROPE COMPRESSION GARMENTS AND STOCKINGS MARKET, BY MATERIAL 215
10.1 OVERVIEW 216
10.2 NYLON & SPANDEX 219
10.3 COTTON 220
10.4 MICROFIBER 220
10.5 BAMBOO FIBER 221
10.6 BREATHABLE MESH / MOISTURE-WICKING FABRICS 221
10.7 WOOL BLENDS 222
10.8 RECYCLED/ORGANIC MATERIALS 222
11 EUROPE COMPRESSION GARMENTS AND STOCKINGS MARKET, BY GENDER 223
11.1 OVERVIEW 224
11.2 WOMEN 227
11.3 UNISEX 228
11.4 MEN 228
12 EUROPE COMPRESSION GARMENTS AND STOCKINGS MARKET, BY DISTRIBUTION CHANNEL 229
12.1 OVERVIEW 230
12.2 OFFLINE 233
12.3 ONLINE 234
13 EUROPE COMPRESSION GARMENTS AND STOCKINGS MARKET, BY END USER 235
13.1 OVERVIEW 236
13.2 GENERAL CONSUMERS 239
13.3 HEALTHCARE INSTITUTIONS 241
13.4 SPORTS TEAMS & CLUBS 241
13.5 CORPORATE WELLNESS PROGRAMS 242
14 EUROPE COMPRESSION GARMENTS AND STOCKINGS MARKET, BY REGION 243
14.1 EUROPE 246
14.1.1 GERMANY 254
14.1.2 FRANCE 261
14.1.3 U.K. 268
14.1.4 ITALY 275
14.1.5 SPAIN 282
14.1.6 RUSSIA 296
14.1.7 BELGIUM 303
14.1.8 NETHERLANDS 310
14.1.9 TURKEY 317
14.1.10 DENMARK 324
14.1.11 NORWAY 331
14.1.12 FINLAND 338
14.1.13 SWEDEN 345
14.1.14 REST OF EUROPE 352
15 EUROPE COMPRESSION GARMENTS AND STOCKINGS MARKET: COMPANY LANDSCAPE 353
15.1 COMPANY SHARE ANALYSIS: GLOBAL 353
16 SWOT ANALYSIS 354
16.1 SWOT ANALYSIS FOR KEY SEGMENTS BY PRODUCT TYPE 354
17 DISTRIBUTOR COMPANY PROFILES 355
17.1 NOVOMED INC PVT. LTD. 355
17.1.1 COMPANY SNAPSHOT 355
17.1.2 PRODUCT PORTFOLIO 355
17.1.3 RECENT DEVELOPMENTS/NEWS 358
17.2 TS COMPROZONE PVT. LTD. 359
17.2.1 COMPANY SNAPSHOT 359
17.2.2 PRODUCT PORTFOLIO 359
17.2.3 RECENT DEVELOPMENTS/NEWS 361
17.3 SIMONSEN & WEEL 362
17.3.1 COMPANY SNAPSHOT 362
17.3.2 PRODUCT PORTFOLIO 362
17.3.3 RECENT DEVELOPMENTS/NEWS 363
17.4 YASHODHAN ENTERPRISE 364
17.4.1 COMPANY SNAPSHOT 364
17.4.2 PRODUCT PORTFOLIO 364
17.4.3 RECENT DEVELOPMENTS/NEWS 365
17.5 YOGI KRIPA 366
17.5.1 COMPANY SNAPSHOT 366
17.5.2 PRODUCT PORTFOLIO 366
17.5.3 RECENT DEVELOPMENTS/NEWS 367
18 MANUFACTURERS, COMPANY PROFILE 368
18.1 BAUERFEIND 368
18.1.1 COMPANY SNAPSHOT 368
18.1.2 COMPANY SHARE ANALYSIS 368
18.1.3 SWOT ANALYSIS 369
18.1.4 PRODUCT PORTFOLIO 369
18.1.5 RECENT DEVELOPMENT 371
18.2 3M 372
18.2.1 COMPANY SNAPSHOT 372
18.2.2 REVENUE ANALYSIS 372
18.2.3 COMPANY SHARE ANALYSIS 373
18.2.4 SWOT ANALYSIS 373
18.2.5 PRODUCT PORTFOLIO 374
18.2.6 RECENT DEVELOPMENTS/NEWS 376
18.3 CARDINAL HEALTH 377
18.3.1 COMPANY SNAPSHOT 377
18.3.2 REVENUE ANALYSIS 377
18.3.3 COMPANY SHARE ANALYSIS 378
18.3.4 SWOT ANALYSIS 378
18.3.5 PRODUCT PORTFOLIO 379
18.3.6 RECENT DEVELOPMENT 380
18.4 THUSANE 382
18.4.1 COMPANY SNAPSHOT 382
18.4.2 COMPANY SHARE ANALYSIS 382
18.4.3 SWOT ANALYSIS 383
18.4.4 PRODUCT PORTFOLIO 383
18.4.5 RECENT DEVELOPMENT 384
18.5 LOHMANN & RAUSCHER GMBH & CO. KG 385
18.5.1 COMPANY SNAPSHOT 385
18.5.2 COMPANY SHARE ANALYSIS 385
18.5.3 SWOT ANALYSIS 386
18.5.4 PRODUCT PORTFOLIO 386
18.5.5 RECENT DEVELOPMENT 387
18.6 AMES WALKER 388
18.6.1 COMPANY SNAPSHOT 388
18.6.2 PRODUCT PORTFOLIO 388
18.6.3 RECENT DEVELOPMENTS/NEWS 389
18.7 CALZIFICIO ZETA SRL 390
18.7.1 COMPANY SNAPSHOT 390
18.7.2 PRODUCT PORTFOLIO 390
18.7.3 RECENT DEVELOPMENT 391
18.8 CEP 392
18.8.1 COMPANY SNAPSHOT 392
18.8.2 PRODUCT PORTFOLIO 392
18.8.3 RECENT DEVELOPMENT 393
18.9 COMPRESSANA GMBH 394
18.9.1 COMPANY SNAPSHOT 394
18.9.2 PRODUCT PORTFOLIO 394
18.9.3 RECENT DEVELOPMENT 397
18.10 GIBAUD 398
18.10.1 COMPANY SNAPSHOT 398
18.10.2 PRODUCT PORTFOLIO 398
18.10.3 RECENT DEVELOPMENT 400
18.11 GLORIA MED S.P.A. 401
18.11.1 COMPANY SNAPSHOT 401
18.11.2 PRODUCT PORTFOLIO 401
18.11.3 RECENT DEVELOPMENT 402
18.12 HEINZ SCHIEBLER GMBH & CO KG 403
18.12.1 COMPANY SNAPSHOT 403
18.12.2 PRODUCT PORTFOLIO 403
18.12.3 RECENT DEVELOPMENT 404
18.13 JUZO 405
18.13.1 COMPANY SNAPSHOT 405
18.13.2 PRODUCT PORTFOLIO 405
18.13.3 RECENT DEVELOPMENT 406
18.14 MAXWELL INDIA 407
18.14.1 COMPANY SNAPSHOT 407
18.14.2 PRODUCT PORTFOLIO 407
18.14.3 RECENT DEVELOPMENT 408
18.15 MEDI GMBH?&?CO.?KG 409
18.15.1 COMPANY SNAPSHOT 409
18.15.2 PRODUCT PORTFOLIO 409
18.15.3 RECENT DEVELOPMENT 410
18.16 NOVAMED 411
18.16.1 COMPANY SNAPSHOT 411
18.16.2 PRODUCT PORTFOLIO 411
18.16.3 RECENT DEVELOPMENT 412
18.17 REJUVA HEALTH 413
18.17.1 COMPANY SNAPSHOT 413
18.17.2 PRODUCT PORTFOLIO 413
18.17.3 RECENT DEVELOPMENT 414
18.18 SANYLEG SRL A SOCIO UNICO 415
18.18.1 COMPANY SNAPSHOT 415
18.18.2 PRODUCT PORTFOLIO 415
18.18.3 RECENT DEVELOPMENT 415
18.19 SCHOLL'S WELLNESS 416
18.19.1 COMPANY SNAPSHOT 416
18.19.2 PRODUCT PORTFOLIO 416
18.19.3 RECENT DEVELOPMENT 418
18.20 SWISSLASTIC AG ST. GALLEN 419
18.20.1 COMPANY SNAPSHOT 419
18.20.2 PRODUCT PORTFOLIO 419
18.20.3 RECENT DEVELOPMENT 420
18.21 SIGVARIS GROUP 421
18.21.1 COMPANY SNAPSHOT 421
18.21.2 PRODUCT PORTFOLIO 421
18.21.3 RECENT DEVELOPMENT 423
18.22 SOCKWELL 424
18.22.1 COMPANY SNAPSHOT 424
18.22.2 PRODUCT PORTFOLIO 424
18.22.3 RECENT DEVELOPMENTS/NEWS 426
18.23 SURGIWEAR 427
18.23.1 COMPANY SNAPSHOT 427
18.23.2 PRODUCT PORTFOLIO 427
18.23.3 RECENT DEVELOPMENT 427
18.24 THERMOTEK 428
18.24.1 COMPANY SNAPSHOT 428
18.24.2 PRODUCT PORTFOLIO 428
18.24.3 RECENT DEVELOPMENT 429
18.25 TYNOR ORTHOTICS PVT. LTD. 430
18.25.1 COMPANY SNAPSHOT 430
18.25.2 PRODUCT PORTFOLIO 430
18.25.3 RECENT DEVELOPMENT 431
18.26 VIM & VIGR 432
18.26.1 COMPANY SNAPSHOT 432
18.26.2 PRODUCT PORTFOLIO 432
18.26.3 RECENT DEVELOPMENTS/NEWS 435
18.27 VISSCO NEXT 436
18.27.1 COMPANY SNAPSHOT 436
18.27.2 PRODUCT PORTFOLIO 436
18.27.3 RECENT DEVELOPMENTS/NEWS 437
18.28 ZENSAH 438
18.28.1 COMPANY SNAPSHOT 438
18.28.2 PRODUCT PORTFOLIO 438
18.28.3 RECENT DEVELOPMENT 439
19 QUESTIONNAIRE 440
20 RELATED REPORTS 444
?